期刊文献+

不同疗程雷贝拉唑四联疗法根除幽门螺杆菌的效果观察 被引量:13

下载PDF
导出
摘要 目的探讨雷贝拉唑联合克拉霉素、奥硝唑、胶体果胶铋四联方案根除幽门螺杆菌(HP)的最佳疗程。方法将284例HP阳性的消化性溃疡和慢性胃炎患者随机分为A组95例、B组95例、C组94例,均予雷贝拉唑、克拉霉素、奥硝唑、胶体果胶铋四联方案,疗程分别为7、9、14 d。疗程结束后分别观察HP根除率、症状缓解率及不良反应发生率。结果三组症状缓解率均较高,组间无显著差异;B、C组根除率均明显高于A组(P均<0.05),B、C组比较无显著差异;三组均出现轻微不良反应,但均能耐受并完成治疗,C组不良反应发生率明显高于A、B组(P均<0.05),A、B组比较无显著差异。结论雷贝拉唑、克拉霉素、奥硝唑、胶体果胶铋四联方案根除HP的最佳疗程为9 d,其具有HP根除率及症状缓解率高、不良反应发生率低等优点,且可减少治疗成本。
出处 《山东医药》 CAS 北大核心 2011年第51期84-85,共2页 Shandong Medical Journal
  • 相关文献

参考文献3

二级参考文献15

  • 1Saad RJ,Schoenfeld P,Kim HM.左氧氟沙星三联疗法治疗顽固性Hp感染优于铋剂四联疗法[J].中国处方药,2006,5(5):42-42. 被引量:40
  • 2中国慢性胃炎共识意见[J].胃肠病学,2006,11(11):674-684. 被引量:834
  • 3Hunt RH,Xiao SD,Megraud F,Leon-Barua R,Bazzoli F,Van der Merwe S,vaz Coelho LG,Fock KM,Fedail S,Cohen H,Malfertheiner P,Vakil N,Hamid S,Goh KL,Wong BC,Krabshuis JH,杜颖,丛衍群,戴宁.世界胃肠病学组织(WGO-OMGE)临床指南——发展中国家幽门螺杆菌感染[J].胃肠病学,2007,12(1):40-52. 被引量:85
  • 4Miwa H,Yamada T,Sato K,et a1.Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection:comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole.Dig Dis Sci,2000,45:77—82.
  • 5Ohara T,Goshi S,Taneike I,et a1.Inhibitory action of a novel proton pump inhibitor,rabeprazole,and its thioether derivative against the growth and motility of clarithromycin-resistant Helicobacter pylori.Helicobacter,2001,6:125-129.
  • 6Miwa H, Yamada T, Sato K, et al. Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection: comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole. Dig Dis Sci, 2000,45(1) :77 - 82
  • 7Tsuchiya M, Imamura L, Park JB, et al. Helicobacter pylori urease inhibition by rabeprazole, a proton pump inhibitor. Biol Pharm Bull,1995,18(8): 1053 - 1056
  • 8Nagata K, Sone N, and Tamura T. Inhibitory Activities of Lansoprazole against Respiration in Helicobacter pylori. Antimicrobial Agents and Chemotherapy, 2001,45(5):1522-1527
  • 9Ohara T, Goshi S, Taneike I, et al. Inhibitory action of a novel proton pump inhibitor, rabeprazole, and its thioether derivative against the growth and motility of clarithromycin - resistant Helicobacter pylori. Helicobacter, 2001,6(2): 125 - 129.In- Vitro Activity of Rabeprazole (Bolite) against Helicobacter pylori.Helicobacter,2001,6(2):125-129
  • 10成虹,胡伏莲,谢勇,胡品津,王吉耀,吕农华,张建中,张桂英,周曾芬,吴克利,张玲霞,彭孝伟,戴宁,唐国都,姜葵,李岩,侯晓华,白文元,王明春,叶红军,刘玉兰,许乐.中国幽门螺杆菌耐药状况以及耐药对治疗的影响—全国多中心临床研究[J].胃肠病学,2007,12(9):525-530. 被引量:518

共引文献120

同被引文献109

引证文献13

二级引证文献175

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部